Nick Zhang has 25+ years of drug R&D experience. He is now the board Chairman and CEO for QIAGEN (Suzhou) Translational Medicine Co., Ltd, a JV with Germany-based GIAGEN . QIAGEN Suzhou provides an integrated technology platform from biomarker discovery and development, to companion diagnostics/Point of Care all the way to clinical testing services.Before QIAGEN, Nick was China GM and Corporate Sr. VP of Frontage Lab. He was responsible for all China business units (CMC, Clinical development and Bioanalytical service) including operation, business and growth. He also served on the SFDA Working Committee for Bayhelix and as reviewer for China Thousand Talents Program.He was a director and China CPP/TRD head for Novartis China R&D center, responsible for supporting local and global projects from Lead optimization to drug product development. He returned to China in 2007 as one of the executive founding members of the center, and contributed greatly to the build-up and strategic planning of the site. Prior to Novartis, Nick was at OSI Pharmaceuticals US site where he was a director of pharmaceutical science division and a department head. After OSI acquired EyeTech in 2006, Nick was part of the integration team for setting up CMC business model and strategies. Nick started his drug industry career at Pfizer global R&D after his Ph.D. During his ten years at Pfizer, Nick led teams at both Early and Full Development Pharmaceutical Science division, filed 6 INDs/IMPD and 1 NDA/MAA for solid, liquid and inhalation dosage forms. Nick represented Pfizer serving on the PRQI (Product Quality and Research Institute) working committee, a joint organization from FDA, industry and academia for science-based regulations. Nick also served in Pfizer Global Leachable/Extractable Taskforce and Regulatory Response Team. Nick worked and studied at Chinese Academy of Sciences, and then at University of Cincinnati in US, where He gained his initial drug research experience.Specialties: Strategic – Entrepreneurial - Learning agility - Communication and management skills – Deep knowledge and rich experience in Drug R&D - Organizational build up – Regulatory experience-Broad professional network-CMC Expert -Formulation and Analytical Development